Cargando…

HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors

The frequent development of drug resistance to targeted therapies in cancer patients has stimulated interest in strategies counteracting resistance. Combining immunotherapies with targeted therapies is one such strategy. In this context, we asked whether human NK cells can target melanoma cells that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sottile, Rosa, Pangigadde, Pradeepa N., Tan, Thomas, Anichini, Andrea, Sabbatino, Francesco, Trecroci, Francesca, Favoino, Elvira, Orgiano, Laura, Roberts, James, Ferrone, Soldano, Kärre, Klas, Colucci, Francesco, Carbone, Ennio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Immunomodulation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832274/ https://www.ncbi.nlm.nih.gov/pubmed/26564811 http://dx.doi.org/10.1002/eji.201445289

Ejemplares similares

Harnessing host innate immunity may combat acquired resistance to BRAFi
por: Tan, Thomas, et al.
Publicado: (2014)

IL‐12/15/18‐preactivated NK cells suppress GvHD in a mouse model of mismatched hematopoietic cell transplantation
por: Hüber, Christian M., et al.
Publicado: (2015)

Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells
por: Magnani, Chiara F, et al.
Publicado: (2011)

A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1
por: Apps, Richard, et al.
Publicado: (2007)

Enrichment of KIR+CD57+ highly cytotoxic NK cells in sentinel lymph nodes of melanoma patients
por: Ali, Talib Hassan, et al.
Publicado: (2014)

Enrichment of CD56(dim)KIR+CD57+ highly cytotoxic NK cells in tumor infiltrated lymph nodes of melanoma patients
por: Ali, Talib Hassan, et al.
Publicado: (2014)

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity
por: Simon, Anna Katharina, et al.
Publicado: (2007)

Regulatory T cells can prevent memory CD8(+) T-cell-mediated rejection following polymorphonuclear cell depletion
por: Jones, Nick D, et al.
Publicado: (2010)

Absence of Rac1 and Rac3 GTPases in the nervous system hinders thymic, splenic and immune-competence development
por: Basso, Veronica, et al.
Publicado: (2011)

Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells
por: Francis, Ross S, et al.
Publicado: (2011)

HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells
por: Che, Karlhans F, et al.
Publicado: (2010)

Exogenous IFN-γ ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3(+) regulatory T cells
por: Feng, Gang, et al.
Publicado: (2008)

Anti-CD4-mediated selection of Treg in vitro – in vitro suppression does not predict in vivo capacity to prevent graft rejection
por: Oliveira, Vanessa, et al.
Publicado: (2008)

Human β-defensin 3 has immunosuppressive activity in vitro and in vivo
por: Semple, Fiona, et al.
Publicado: (2010)

Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region
por: Wooldridge, Linda, et al.
Publicado: (2007)

Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells
por: Rossetti, Maura, et al.
Publicado: (2010)

Arginine depletion as a mechanism for the immune privilege of corneal allografts
por: Fu, Hongmei, et al.
Publicado: (2011)

Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition
por: Khan, Adnan, et al.
Publicado: (2013)

PD-1 modulates steady-state and infection-induced IL-10 production in vivo
por: McBerry, Cortez, et al.
Publicado: (2014)

Exacerbated experimental arthritis in Wiskott–Aldrich syndrome protein deficiency: Modulatory role of regulatory B cells
por: Bouma, Gerben, et al.
Publicado: (2014)

Human β-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF
por: Semple, Fiona, et al.
Publicado: (2011)

IL-33 attenuates the development of experimental autoimmune uveitis
por: Barbour, Mark, et al.
Publicado: (2014)

Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter
por: Hill, Elaine V, et al.
Publicado: (2015)

OX40 controls effector CD4(+) T-cell expansion, not follicular T helper cell generation in acute Listeria infection
por: Marriott, Clare L, et al.
Publicado: (2014)

Progesterone promotes maternal–fetal tolerance by reducing human maternal T‐cell polyfunctionality and inducing a specific cytokine profile
por: Lissauer, David, et al.
Publicado: (2015)

Exposure to inflammatory cytokines selectively limits GM-CSF production by induced T regulatory cells
por: Reynolds, Ben C, et al.
Publicado: (2014)

Signal regulatory protein alpha (SIRPα) regulates the homeostasis of CD103(+)CD11b(+) DCs in the intestinal lamina propria
por: Scott, Charlotte L, et al.
Publicado: (2014)

Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage
por: Schminke, Boris, et al.
Publicado: (2015)

The site of allergen expression in hematopoietic cells determines the degree and quality of tolerance induced through molecular chimerism
por: Baranyi, Ulrike, et al.
Publicado: (2013)

IL‐12 and IL‐4 activate a CD39‐dependent intrinsic peripheral tolerance mechanism in CD8(+) T cells
por: Noble, Alistair, et al.
Publicado: (2016)

NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis
por: Reppert, Sarah, et al.
Publicado: (2015)

Non‐glycosidic compounds can stimulate both human and mouse iNKT cells
por: Jukes, John‐Paul, et al.
Publicado: (2016)

Mutant B2M‐HLA‐E and B2M‐HLA‐G fusion proteins protects universal chimeric antigen receptor‐modified T cells from allogeneic NK cell‐mediated lysis
por: Guo, Yelei, et al.
Publicado: (2021)

Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAF(V600E) melanoma
por: Sabbatino, F, et al.
Publicado: (2015)

Iron and Ferritin Modulate MHC Class I Expression and NK Cell Recognition
por: Sottile, Rosa, et al.
Publicado: (2019)

Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression
por: McCarthy, Michael T., et al.
Publicado: (2019)

PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation
por: Sabbatino, Francesco, et al.
Publicado: (2014)

Rat embryonic fibroblasts immortalized by MRPS18-2 protein are target for NK-cells
por: Mushtaq, Muhammad, et al.
Publicado: (2017)

A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction
por: Carbone, Ennio, et al.
Publicado: (1997)

High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease
por: Nota, Sjoerd P. F. T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mh46jieca1sofid2n5ejlpd1ct